PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAvanir Pharmaceuticals
Avanir Pharmaceuticals(AVNR)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
NuedextaDextromethorphan, Quinidine2010-10-292023-2040
Atrial fibrillation
,
Atrial flutter
,
Cardiac arrhythmias
,
Cough
,
Neurobehavioral manifestations
,
Sinusitis
,
Asthma
,
Common cold
,
Allergic rhinitis perennial
,
Urticaria
,
Vasomotor rhinitis
,
Whooping cough
,
Bronchitis
,
Pharyngitis
,
Laryngitis
,
Postoperative complications
,
Pain
,
Vomiting
,
Nausea
,
Anaphylaxis
,
Allergic conjunctivitis
,
Motion sickness
,
Tobacco use disorder
,
Attention deficit disorder with hyperactivity
,
Depressive disorder
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Dextromethorphan
respiratory tract infections
,
common cold
Quinidine gluconate
healthy volunteers/patients
,
schizophrenia
,
depression
,
treatment-resistant depressive disorder
,
major depressive disorder
,
depressive disorder
,
dyskinesias
,
psychomotor agitation
,
neuralgia
,
migraine disorders
,
disease progression
,
sclerosis
,
parkinson disease
,
multiple sclerosis
,
amyotrophic lateral sclerosis
,
pain
,
diabetic neuropathies
,
motor neuron disease
,
pseudobulbar palsy
,
alzheimer disease
,
stroke
,
traumatic brain injuries
,
brain injuries
,
dementia
Quinidine polygalacturonate
healthy volunteers/patients
,
schizophrenia
,
depression
,
treatment-resistant depressive disorder
,
major depressive disorder
,
depressive disorder
,
dyskinesias
,
psychomotor agitation
,
neuralgia
,
migraine disorders
,
disease progression
,
sclerosis
,
parkinson disease
,
multiple sclerosis
,
amyotrophic lateral sclerosis
,
pain
,
diabetic neuropathies
,
motor neuron disease
,
pseudobulbar palsy
,
alzheimer disease
,
stroke
,
traumatic brain injuries
,
brain injuries
,
dementia
Quinidine
healthy volunteers/patients
,
drug interactions
,
respiratory syncytial virus infections
,
hepatitis b
,
non-alcoholic fatty liver disease
,
fatty liver
,
constipation
,
covid-19
,
major depressive disorder
,
depressive disorder
,
depression
,
malaria
,
migraine disorders
,
disease progression
,
treatment-resistant depressive disorder
,
dyskinesias
,
autistic disorder
,
neuralgia
,
thrombosis
,
impulse control disruptive and conduct disorders
,
aggression
,
psychomotor agitation
,
cardiac arrhythmias
,
amyotrophic lateral sclerosis
,
sclerosis
,
motor neuron disease
,
parkinson disease
,
cardiovascular diseases
,
heart diseases
,
ventricular fibrillation
,
syndrome
,
brugada syndrome
,
schizophrenia
,
multiple sclerosis
,
huntington disease
,
irritable mood
,
pain
,
diabetic neuropathies
,
ischemic stroke
,
blood coagulation disorders
,
hemostatic disorders
,
renal insufficiency
,
heart failure
,
myocardial infarction
,
heart arrest
,
infarction
,
ventricular tachycardia
,
sudden death cardiac
,
tachycardia
,
sudden death
,
alzheimer disease
,
dementia
,
atrial fibrillation
,
brain injuries
,
pseudobulbar palsy
,
traumatic brain injuries
,
stroke
,
metabolic clearance rate
,
anemia
,
vascular dementia
,
hypoxia
,
lewy body disease
,
neurodegenerative diseases
,
hyperhomocysteinemia
,
vitamin b 12 deficiency
,
tauopathies
,
frontotemporal dementia
,
tdp-43 proteinopathies
,
primary progressive aphasia
,
pick disease of the brain
,
cognitive dysfunction
,
iron deficiencies
Alfacalcidol
heart failure
,
hypoxia
,
altitude
Tiratricol
healthy volunteers/patients
Neurodex
pain
,
diabetic neuropathies
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use